Importantly, Cerchietti and colleagues showed that HSP90 interacts with B-cell lymphoma-6 (Bcl-6) which was further supported by the finding that HSP90 inhibitor PU-H71 selectively killed Bcl-6-dependent DLBCL cells (109). This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.